Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
about
MicroRNAS in endometrial cancer: recent advances and potential clinical applicationsGuidelines for the design, analysis and interpretation of 'omics' data: focus on human endometriumImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerMiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanismThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyPrognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-AnalysisLarge oncosomes mediate intercellular transfer of functional microRNA.Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas.miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.Circulating MicroRNAs in gynecological malignancies: from detection to predictionVerification of microRNA expression in human endometrial adenocarcinoma.Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissuesMicroRNA expression in human endometrial adenocarcinomaA TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cellsmiREC: a database of miRNAs involved in the development of endometrial cancer.Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis.The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing.MicroRNA-200 Family Profile: A Promising Ancillary Tool for Accurate Cancer DiagnosisPrognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancerMicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.Circulating microRNAs predict biochemical recurrence in prostate cancer patients.Prognostic significance of miR-194 in endometrial cancer.Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.Assessment of differentially expressed plasma microRNAs in nonsyndromic cleft palate and nonsyndromic cleft lip with cleft palate.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN.Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.MicroRNAs in gynecological cancers: Small molecules with big implications.Absent MicroRNAs in Different Tissues of Patients with Acquired CardiomyopathyIdentification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.
P2860
Q26780358-ADF95F4C-B9FB-49FA-88CE-91E536E40F44Q27012789-6FF17E6B-018F-4E97-9733-DA7BF0FD0D94Q27016123-1E2242C0-A385-4736-840E-CC33EDABE9AAQ27342777-D9D90AEB-1026-4DE4-94B4-41378EBE8BDDQ28083742-94E7FDA4-F7E3-4B16-9897-3813E0DC1284Q30235175-43D8314D-74EC-470F-A863-5AB204E28F33Q30570006-89AAE423-94A5-4FF0-BEE9-639C9842BC24Q33274852-C7715974-5641-44C8-99FE-5B5DE62DD7D8Q33709560-2DE562A2-30A5-432C-BC83-E1FF833874A1Q33718986-9203C6D0-F9C3-4603-8B6B-6598CFEA5825Q33816414-4D4A2755-137D-4E5D-9777-E2D3F158E5D1Q34346375-1840CD7A-B3C7-473D-B211-9EFFEBB823E8Q34489328-7B9B0CA1-E368-49B1-B785-F10DF938801EQ34558443-52B3D78B-4CD3-470A-BE9D-A2EB5132F4D3Q35062900-BACB3E5C-E00B-449A-9DF2-C72D6F197021Q35247692-E8A02D05-93A5-40EA-8EC5-B4609F37A58EQ35479630-A593A22A-15D3-4456-80FE-6E1B524145C9Q35482100-A1D14AD2-0BFF-44B9-BF1E-B476C064B5FFQ35632200-73C11E0F-AA13-4CE0-A796-22F67661302DQ35687197-46338EFA-91E8-4052-B081-ED766BB37D8AQ35855574-C18A2D3A-9023-4A56-9A6D-8320B5B3CBBCQ36162978-79AE5E08-D8E8-4F3B-B2E0-90DF8116F4A4Q36174701-0F2379BC-A28B-4C04-9BAC-8C42E8C1A300Q37007297-CD3AAF79-1AEB-4007-A59E-2D564177508BQ37029456-66D68AA2-ED13-4410-8313-54EE72B5DAD4Q37081843-A608072A-BD7A-4555-9973-A3CF93B42B28Q37169644-FB4ED1BC-41CC-4AAB-83F2-8B2442C93AA8Q37582086-70BBBA03-DAA8-4BCD-9E61-8E614B0B13E1Q37687451-A4AB15DC-2E3A-47A9-9B5E-C5B764B02BDFQ37699227-43180677-3713-4422-A61A-C265CB49B8A2Q38258014-C56318EC-F22A-4D84-8361-D1EDCB87CA2BQ38820391-11ED0032-3D6E-4409-9486-DE88ACBE9ED7Q39035242-8B1467F9-B90E-473D-8595-2CEDD7AA2AE4Q39077807-057A3E27-F357-4C4C-9159-81E9749F3D4AQ39154029-F714546A-9F4D-4520-AE14-E8FC07E7271FQ39317584-F0FE33E6-8944-4E70-9508-2C96A8ED387BQ39333266-0D6E511A-B291-4A97-88F7-EBC474E589D1Q39542328-33B9C592-39A6-4FFD-9D70-6781A4D8AF6EQ40928879-4F42BA40-8763-4730-9F35-B266EC1C5FDAQ41592814-87245467-A1FE-485D-B569-D2BC890D3D5C
P2860
Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@en
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@nl
type
label
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@en
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@nl
prefLabel
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@en
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@nl
P2093
P2860
P356
P1476
Diagnostic and prognostic sign ...... ndometrial carcinoma patients.
@en
P2093
Anna Pesci
Anna Torres
Marcello Ceccaroni
Paola Cassandrini
Ryszard Maciejewski
Tomasz Paszkowski
P2860
P304
P356
10.1002/IJC.27840
P577
2012-10-17T00:00:00Z